Package 82009-051-05

Brand: bupropion hydrochloride xl

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 82009-051-05
Digits Only 8200905105
Product NDC 82009-051
Product ID 82009-051_cd0aee48-be2a-4cc8-964d-fcc1c991c185
Description

500 TABLET, EXTENDED RELEASE in 1 BOTTLE (82009-051-05)

Marketing

Marketing Status
Marketed Since 2023-07-07
Brand bupropion hydrochloride xl
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Bupropion Hydrochloride XL ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "cd0aee48-be2a-4cc8-964d-fcc1c991c185", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["56df4e22-81ca-48a4-a8e2-038448417355"], "manufacturer_name": ["Quallent Pharmaceuticals Health LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (82009-051-05)", "package_ndc": "82009-051-05", "marketing_start_date": "20230707"}], "brand_name": "Bupropion Hydrochloride XL", "product_id": "82009-051_cd0aee48-be2a-4cc8-964d-fcc1c991c185", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "82009-051", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Quallent Pharmaceuticals Health LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "XL", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA090693", "marketing_category": "ANDA", "marketing_start_date": "20230707", "listing_expiration_date": "20261231"}